Matches in SemOpenAlex for { <https://semopenalex.org/work/W3184982203> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W3184982203 abstract "Abstract The aim of this study was to evaluate the vision-related quality of life (VR-QOL) before and after intravitreal ranibizumab injections (IVR) for central retinal vein occlusion (CRVO) and investigate subscale items of VR-QOL in detail. This multicenter, open-label, prospective study included 23 patients with treatment naïve CRVO and 22 age-matched normal controls. VR-QOL was assessed by the 25-Item Visual Function Questionnaire (VFQ-25) before and up to 12 months post-treatment. The VFQ-25 composite score and 12 subscales were compared between groups. The VFQ-25 composite scores in CRVO showed significant improvement throughout the treatment period compared with those at the baseline. The VFQ-25 composite score before and after treatment in CRVO was significantly lower than that in normal controls. The subscale items, including general health, general vision, near activities, social functioning, mental health, role difficulties, dependency, and peripheral vision, in CRVO were significantly lower than those in the normal controls even after treatment. Vision-related QOL was low in patients with CRVO before treatment and improved with IVR. Even after treatment, the values of several subscale items were lower than those in normal controls. Patients with CRVO require treatment aimed at further improving visual function as well as social and psychological care." @default.
- W3184982203 created "2021-08-02" @default.
- W3184982203 creator A5007755064 @default.
- W3184982203 creator A5036747852 @default.
- W3184982203 creator A5039990488 @default.
- W3184982203 creator A5047796053 @default.
- W3184982203 creator A5075007945 @default.
- W3184982203 creator A5088472844 @default.
- W3184982203 date "2021-07-20" @default.
- W3184982203 modified "2023-10-16" @default.
- W3184982203 title "Vision-Related Quality of Life and Subscale Items Following Intravitreal Ranibizumab Injections for Central Retinal Vein Occlusion" @default.
- W3184982203 doi "https://doi.org/10.21203/rs.3.rs-724586/v1" @default.
- W3184982203 hasPublicationYear "2021" @default.
- W3184982203 type Work @default.
- W3184982203 sameAs 3184982203 @default.
- W3184982203 citedByCount "0" @default.
- W3184982203 crossrefType "posted-content" @default.
- W3184982203 hasAuthorship W3184982203A5007755064 @default.
- W3184982203 hasAuthorship W3184982203A5036747852 @default.
- W3184982203 hasAuthorship W3184982203A5039990488 @default.
- W3184982203 hasAuthorship W3184982203A5047796053 @default.
- W3184982203 hasAuthorship W3184982203A5075007945 @default.
- W3184982203 hasAuthorship W3184982203A5088472844 @default.
- W3184982203 hasBestOaLocation W31849822031 @default.
- W3184982203 hasConcept C118487528 @default.
- W3184982203 hasConcept C126322002 @default.
- W3184982203 hasConcept C159110408 @default.
- W3184982203 hasConcept C1862650 @default.
- W3184982203 hasConcept C188816634 @default.
- W3184982203 hasConcept C2776268601 @default.
- W3184982203 hasConcept C2776694085 @default.
- W3184982203 hasConcept C2777802072 @default.
- W3184982203 hasConcept C2778257484 @default.
- W3184982203 hasConcept C2778844676 @default.
- W3184982203 hasConcept C2779951463 @default.
- W3184982203 hasConcept C2780347916 @default.
- W3184982203 hasConcept C2781100027 @default.
- W3184982203 hasConcept C71924100 @default.
- W3184982203 hasConceptScore W3184982203C118487528 @default.
- W3184982203 hasConceptScore W3184982203C126322002 @default.
- W3184982203 hasConceptScore W3184982203C159110408 @default.
- W3184982203 hasConceptScore W3184982203C1862650 @default.
- W3184982203 hasConceptScore W3184982203C188816634 @default.
- W3184982203 hasConceptScore W3184982203C2776268601 @default.
- W3184982203 hasConceptScore W3184982203C2776694085 @default.
- W3184982203 hasConceptScore W3184982203C2777802072 @default.
- W3184982203 hasConceptScore W3184982203C2778257484 @default.
- W3184982203 hasConceptScore W3184982203C2778844676 @default.
- W3184982203 hasConceptScore W3184982203C2779951463 @default.
- W3184982203 hasConceptScore W3184982203C2780347916 @default.
- W3184982203 hasConceptScore W3184982203C2781100027 @default.
- W3184982203 hasConceptScore W3184982203C71924100 @default.
- W3184982203 hasLocation W31849822031 @default.
- W3184982203 hasOpenAccess W3184982203 @default.
- W3184982203 hasPrimaryLocation W31849822031 @default.
- W3184982203 hasRelatedWork W1997095687 @default.
- W3184982203 hasRelatedWork W2061916858 @default.
- W3184982203 hasRelatedWork W2068100937 @default.
- W3184982203 hasRelatedWork W2413823267 @default.
- W3184982203 hasRelatedWork W2518914114 @default.
- W3184982203 hasRelatedWork W2521155275 @default.
- W3184982203 hasRelatedWork W2588621177 @default.
- W3184982203 hasRelatedWork W3193497743 @default.
- W3184982203 hasRelatedWork W4205243730 @default.
- W3184982203 hasRelatedWork W3115407169 @default.
- W3184982203 isParatext "false" @default.
- W3184982203 isRetracted "false" @default.
- W3184982203 magId "3184982203" @default.
- W3184982203 workType "article" @default.